Document is current

Any future updates will be listed below

Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: results of the CECOG LaVie trial

Crossref DOI link: https://doi.org/10.1186/s12885-016-2171-y

Published Online: 2016-02-18

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark